The calculation of behavioral health quality measures at the clinic level holds great promise for monitoring clinic performance over time, and for providing information for clinics to use to revise their processes and procedures to improve their performance.
Report
Reports
Displaying 71 - 80 of 299. 10 per page. Page 8.
Advanced SearchReport
Feasibility of Calculating Measures to Monitor Quality Performance of Behavioral Health Programs
Report
Exploring Patient Care Navigation in the Medicare Program
Patient navigation provides support and information to patients and their families to help navigate the complexities of health care services. These programs or services may include providing support and resources to inform clinical patient choices, financial responsibilities, and available social and community services.
Report
Impact of Drug Shortages on Patients in the United States: A Case Study of Three Drugs
Drug shortages are a persistent problem that can cause substantial disruption in patient treatment regimens and adversely impact a patient’s health. Drug shortages can have severe consequences for patients, including high costs, delayed care, and potential medication errors or unintended side effects when using alternative or unfamiliar drugs.
Report
The Availability, Quality, and Use of Administrative Data to Identify and Reduce Health and Human Services-Related Disparities: A Survey of HHS-Funded Programs and Interventions
Executive Orders No. 13985 (2021) and 14091 (2023) require federal agencies to ensure that their policies and services, including data collection, advance equitable outcomes for all populations. The Assistant Secretary for Planning and Evaluation (ASPE) and the U.S.
Report
The Fiscal Impact of Refugees and Asylees at the Federal, State, and Local Levels from 2005-2019
This report does not represent the views or policies of the Department of Health and Human Services or the Trump Administration. It was published in 2024 and is provided only for historical purposes.
Report
Comparing Prescription Drugs in the U.S. and Other Countries: Prices and Availability
ASPE contracted with RAND Health Care to carry out three studies analyzing data on U.S. prescription drug prices and availability in comparison to drug prices and availability in other Organisation for Economic Co-operation and Development (OECD) countries. In 2022, U.S. prices across all drugs (brands and generics) were nearly 2.78 times as high as prices in the comparison countries. U.S.
Report
State Efforts to Coordinate Provider Directory Accuracy
Provider directories are lists of in-network providers produced by health care plans. They are an important tool for individuals seeking health care providers, and for regulators who monitor the adequacy of health plans’ provider networks.
Report
Claims and Provider Payment Data Gaps for Responding to COVID-19
This report and accompanying discussion by ASPE and NORC highlights the claims data limitations identified during the COVID-19 Public Health Emergency Health (PHE) and provides considerations to address these limitations. The report identifies that limitations related to claims data were existing issues, exacerbated by, but not unique to, the COVID-19 PHE.
Report, Research Brief
Reconnecting Youth: Evidence Gap Map
Evidence Gap Map: Research Report and Overview
Report, Research Brief
Reconnecting Youth: Compendium of Programs
Compendium of Programs: Research Report and Overview The Reconnecting Youth compendium of programs provides an overview of 78 programs and the practices they employ to support young people who experience disconnection from school and work during their transition to adulthood.